Incorporating Relevant and Meaningful ?Patient-Reported Outcomes in ?RCC Clinical Trials?

Incorporating Relevant and Meaningful ?Patient-Reported Outcomes in ?RCC Clinical Trials?

User Photo
kidneycancer

1 year
126 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Bellinda King-Kallimanis, PhD of U.S. Food and Drug Administration, Maryland (FDA ) discusses Incorporating Relevant and Meaningful ?Patient-Reported Outcomes in ?RCC Clinical Trials? at the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
Up Next Autoplay
>